M&A Deal Summary

Creat Group Company Acquires BPL

On May 18, 2016, Creat Group Company acquired life science company BPL from Bain Capital Private Equity for 820M GBP

Acquisition Highlights
  • This is Creat Group Company’s 1st transaction in the Life Science sector.
  • This is Creat Group Company’s largest (disclosed) transaction.
  • This is Creat Group Company’s 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2016-05-18
Target BPL
Sector Life Science
Buyer(s) Creat Group Company
Sellers(s) Bain Capital Private Equity
Deal Type Add-on Acquisition
Deal Value 820M GBP

Target

BPL

Hertfordshire, United Kingdom
BPL is a manufacturer of plasma-derived protein therapies. The company exports to more than 45 countries worldwide. BPL has over 60 years of experience developing and manufacturing plasma-derived therapies since being established as part of the Lister Institute in 1950, and currently markets a wide range of products including coagulation factors, human immunoglobulins, and albumin. BPL is committed to continued investment in research and development to maintain its key position as a reliable supplier of high-quality products to patients and healthcare providers worldwide.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Creat Group Company

Beijing, China
Category Company
Founded 1992
Sector Manufacturing
DESCRIPTION

Creat Group Company Ltd. is a manufacturer of Industrial Conglomerates.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (United Kingdom) 1 of 1
Year (2016) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Bain Capital Private Equity

Boston, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1984
PE ASSETS 44.2B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Bain Capital Private Equity (BCPE), is the private equity investment arm of alternative asset management firm, Bain Capital. BCPE targets leveraged buyout and growth capital transactions in a wide variety of industries including information technology, communications, media, healthcare, industrial/manufacturing, retail/consumer, and financial services. Bain Capital is based in Boston with additional offices in New York, London, Mumbai, Hong Kong, Shanghai, Tokyo, and Munich.

DEAL STATS #
Overall 79 of 143
Sector (Life Science) 4 of 6
Type (Add-on Acquisition) 21 of 40
Country (United Kingdom) 2 of 7
Year (2016) 3 of 15
Size (of disclosed) 24 of 44
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-02 Vertafore

Denver, Colorado, United States

Vertafore, Inc. is a cloud-based software that provides agency management, compliance, workflow, and data solutions that simplify and automate the complex property and casualty (“P&C”) insurance lifecycle. More than 20,000 agencies and 1,000 insurance carriers rely on Vertafore to streamline their processes, improve efficiency, and drive productivity. Vertafore, Inc. was founded in 1969 and is based in Denver, Colorado.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-19 ASIMCO

Beijing, China

ASIMCO is a manufacturer of automotive and heavy-duty truck components in China.

Sell €78M
Mergr

Product

Company

Legal